Developer docs
API playgroundTry for free, no card

Search company profiles

Vielight

Full company profile

uuid000669g

Namestring
Vielight
Legal namestring
Vielight Inc.
Websiteurl
vielight.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Vielight Inc. is a Toronto-based neurotechnology company founded in 2012 by Dr. Lew Lim that develops and sells at-home photobiomodulation (PBM) devices targeting brain and systemic health. Its core technology is a patented intranasal-transcranial PBM (itPBM) architecture using 810nm near-infrared Vie-LED modules that combine transcranial delivery (via concave-lens modules that bypass hair and scalp) with intranasal delivery through the cribriform plate to reach deep brain structures including the hippocampus, hypothalamus, and brainstem. The product portfolio spans the Neuro 4 series (Gamma 4 at $1,799, Alpha 4, Duo 4 at $2,399, and Pro 2 at $5,000 with 400 mW/cm² irradiance), the MIP multi-wavelength systemic device ($499), the X-Plus 4 for thymus stimulation ($449), and the Vagus NIR vagus nerve stimulator ($699), with devices certified to ISO 13485, MDSAP, and TÜV Rheinland standards.

Vielight sells primarily direct-to-consumer through its e-commerce platform (vielight.com) with global shipping, augmented by a 500+ practitioner channel, elite sports partnerships (BYU football, Haas Factory Team/NASCAR, UFC champion Ilia Topuria), and a government channel via the VA and Lovell Government Services for US veterans. The company also operates VIECLINIC, a Toronto psychiatric and neurological clinic combining EEG, rTMS, tDCS, and tPBM, and is preparing the soft launch of the Vielight-AI platform for EEG analysis in early 2026. Revenue is generated through one-time hardware sales with optional AI platform access bundled in (6-12 months depending on device tier), HSA/FSA eligibility, and reseller/affiliate commissions.

The company has positioned itself as the evidence leader in home-use brain PBM, claiming 30+ peer-reviewed studies with independent top-tier institutions including UCSF, Harvard Medical School, University of Toronto, University of Utah, Baycrest, and CAMH, with 100,000+ devices sold worldwide. A 228-participant pivotal Alzheimer's trial is underway with FDA and Health Canada protocol review, and a $4.6 million US Department of War grant is funding a 300-participant TBI trial at University of Utah and NYU. The company has raised a $3.5 million seed round from MaRS Discovery District and remains founder-controlled under Dr. Lew Lim.

Short descriptiontext

Vielight, based in Toronto, Canada is increasingly recognized to be the company that offers some of the most user-friendly

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
brain photobiomodulation devices, near-infrared neurotechnology, intranasal light therapy, transcranial PBM systems, cognitive wellness hardware
Industry1 code
PRIMARYHDAHALAL
Optoelectronic Emitters (LED/Laser/VCSEL)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Consumer Neurotechnology
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware device sales
TypeHardware Sales
Description

Vielight generates revenue primarily through direct sales of neurotechnology devices (brain PBM headsets and intranasal modules) priced from $449 to $5,000. Devices include Neuro Gamma 4 ($1,799), Neuro Duo 4 ($2,399), Neuro Pro 2 ($5,000), Neuro Alpha 4, MIP, X-Plus, and Vagus. One-time hardware purchase model with optional AI platform access.

vielight.com
2VIECLINIC professional services
TypeProfessional Services
Description

Vielight operates VIECLINIC, a psychiatric and neurological clinic in Toronto combining EEG, rTMS, tDCS, and tPBM technologies, generating professional services revenue.

vielight.com
3Practitioner/reseller programs
TypeAffiliate Referral
Description

Practitioners program enables clinicians to incorporate Vielight brain PBM technology into their practice with dedicated client support channels. Reseller and affiliate programs offer commissions and reseller discounts, creating channel-based revenue.

vielight.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details7 tiers
1Vielight Neuro Gamma 4 — Gamma 40Hz brain PBM device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$1,799. 20-minute sessions. 810nm Vie-LEDs. 40Hz Gamma pulse rate for focus and memory. Includes 6 months partial Vielight-AI access. ISO13485 and MDSAP certified. TÜV Rheinland safety certified.

vielight.com
2Vielight Neuro Duo 4 — Dual Alpha + Gamma device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$2,399. Access to both Alpha (10Hz) and Gamma (40Hz) pulse rates. Enables switching between relaxation (Alpha) and focus (Gamma) modes. 6 months partial Vielight-AI access included.

vielight.com
3Vielight Neuro Pro 2 — Most powerful customizable brain PBM device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$5,000. The most powerful and customizable brain PBM device. 9 preset protocols via Neuro Pro App. 400 mW/cm² irradiance. 12 months of partial Vielight-AI access included. Includes pre-synced smartphone with Neuro Pro App.

vielight.com
4Vielight Neuro Alpha 4 — Alpha 10Hz relaxation device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Alpha brain wave modulation at 10Hz for relaxation, mindfulness, and learning. Part of the Neuro 4 lineup.

vielight.com
5Vielight MIP — Multi-wavelength systemic/intranasal device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$499. 470-633-655-810nm multi-wavelength. Improves immunity, oxygenation, gentle brain stimulation. 25-minute sessions. Also helps with intranasal microbial sanitization.

vielight.com
6Vielight X-Plus 4 — Thymus and nasal vasculature stimulation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$449. Stimulates thymus gland and nasal vasculature with light energy. Improves immunity and systemic fitness.

vielight.com
7Vielight Vagus — Non-invasive vagus nerve stimulation via PBM
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$699. Non-invasive NIR vagus nerve stimulation. Enhances brain-body connectivity, mental clarity, stress reduction, physical and mental wellbeing. Combined with Neuro Duo: $3,098.

vielight.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Vieclinic
Description

Psychiatric and neurological clinic combining EEG, rTMS, tDCS, and tPBM technologies

vielight.com
+3 more records
Core offering1 text field

Vielight designs, manufactures, and sells at-home brain photobiomodulation (PBM) devices that deliver 810nm near-infrared light through a patented intranasal-transcranial (itPBM) architecture to reach deep brain structures. Its Neuro product line (Gamma, Alpha, Duo, Pro 2) targets cognition, memory, focus, and recovery, complemented by systemic devices (MIP, X-Plus, Vagus) and an EEG-analysis AI platform. The company also operates VIECLINIC, a Toronto psychiatric and neurological clinic.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Episodic recognition memory improved by large effect size (d=1.09, p=0.02) in MCI patients using Vielight Neuro itPBM for 6 weeks vs. sham
+7 more records
Product overview1 text field

Vielight is a neurotechnology company offering a portfolio of at-home brain and systemic photobiomodulation (PBM) devices. The core product line includes the Neuro series (Neuro Gamma 4, Neuro Alpha 4, Neuro Duo 4, and Neuro Pro 2) which deliver 810nm near-infrared light via transcranial and intranasal (itPBM) routes to target brain networks. Supporting devices include the MIP for systemic immunity, X-Plus for thymus/nasal stimulation, and Vagus for vagus nerve stimulation. The ecosystem is complemented by the Vielight-AI platform (AI/ML-powered EEG analysis) and VIECLINIC (clinical services). All brain devices use proprietary Vie-LED technology with industry-leading irradiance and are backed by 30+ published peer-reviewed studies.

Product and service9 records
1Vielight Neuro Gamma 4
CategoryBrain PBM Hardware
Description

Transcranial-intranasal PBM helmet delivering 810nm near-infrared light at 40Hz Gamma frequency via five Vie-LED modules and a patented intranasal applicator, designed to enhance cognition, memory, and brain resilience.

2Vielight Neuro Alpha 4
CategoryBrain PBM Hardware
Description

Brain PBM device that pulses near-infrared light at 10Hz Alpha frequency through combined transcranial and intranasal delivery to support relaxation, mindfulness, learning, and recovery.

3Vielight Neuro Duo 4
CategoryBrain PBM Hardware
Description

Dual-frequency brain PBM device that combines Alpha (10Hz) and Gamma (40Hz) pulsed modes, allowing users to switch between relaxed and focused mental states.

4Vielight Neuro Pro 2
CategoryBrain PBM Hardware
Description

Most powerful and customizable Vielight brain PBM device featuring 9 preset protocols via the Neuro Pro App, 400 mW/cm² irradiance, and a pre-synced smartphone for guided brain photobiomodulation sessions.

5Vielight MIP 470-633-655-810
CategorySystemic PBM Hardware
Description

Multi-wavelength systemic/intranasal PBM device combining 470, 633, 655, and 810nm light to support immunity, oxygenation, gentle brain stimulation, and intranasal microbial sanitization.

6Vielight X-Plus 4
CategorySystemic PBM Hardware
Description

Device that stimulates the thymus gland and nasal vasculature with light energy to improve immunity and systemic fitness.

7Vielight Vagus
CategorySystemic PBM Hardware
Description

Non-invasive near-infrared vagus nerve stimulator that uses photobiomodulation to enhance brain-body connectivity, mental clarity, stress reduction, and physical and mental wellbeing.

8Vielight-AI Platform
CategorySoftware Platform
Description

AI and machine learning platform that analyzes EEG data files to help researchers, clinicians, and home users assess how their brain responds to brain photobiomodulation.

9VIECLINIC
CategoryClinical Services
Description

Toronto-based psychiatric and neurological clinic operated by Vielight that combines EEG, rTMS, tDCS, and transcranial PBM technologies for comprehensive neurotechnology-based brain interventions.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1Haas Factory Team (NASCAR)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-18
Description

Vielight partnered with Haas Factory Team (NASCAR) in June 2026 to bring brain health into the sports conversation. The partnership aims to raise awareness of neurotechnology for athletes, emphasizing brain health considerations from high-speed racing to contact sports. Represents Vielight's expansion into motorsports for visibility and sports performance validation.

vielight.com
2University of Toronto
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple research collaborations with University of Toronto including the MCI pilot trial (n=20, published in Journal of Alzheimer's Disease June 2026), ongoing n=60 MCI clinical trial, viral recovery study, and EEG neuromodulation study. Key researchers include Dr. Neda Rashidi-Ranjbar (MD, PhD) and Dr. Corinne Fischer (MD, PhD).

vielight.com
3St. Michael's Hospital (Toronto)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical trial site for Vielight's MCI research and pivotal Alzheimer's trial (n=228). St. Michael's Hospital is a major teaching hospital affiliated with the University of Toronto. Dr. Corinne Fischer serves as principal investigator. The hospital's Applied Health Research Centre (AHRC) independently manages the pivotal Alzheimer's trial.

vielight.com
4University of Utah
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multi-phase TBI research collaboration with University of Utah's Traumatic Brain Injury and Concussion Center. Phase 1 (n=49) and Phase 2 (n=44) published studies showing cognitive and motor improvements. Currently leading the landmark $4.6M DoD-funded 300-participant clinical trial. Key researchers: Dr. Elisabeth Wilde and Dr. Carrie Esopenko. Published in Journal of Neurotrauma (2026).

vielight.com
5Baycrest Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Published study (n=45) investigating Vielight's itPBM technology's effect on the brain's glymphatic system (waste clearance network). Key finding: intranasal channel is 20x more efficient than transcranial-only at improving brain fluid dynamics. Study highlights the efficiency advantage of Vielight's dual-pathway approach.

vielight.com
6Brigham Young University (BYU)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

BYU football team adopted Vielight Neuro Duo as standard equipment for the 2024 season (11-2 record, No. 13 AP ranking). Tom Holmoe, 3x Super Bowl Champion and BYU Associate Athletic Director, cited compelling photobiomodulation research from University of Utah. Performance research team led by Dr. Coleby Cloawson. Two NFL teams reportedly evaluating the technology.

vielight.com
7Lovell Government Service / VA
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership to serve US veterans and service members with Vielight neurotechnology through the VA (Veterans Affairs) system. Provides access to Vielight devices for veterans, particularly those with mTBI and cognitive concerns.

vielight.com
8Centre for Addiction and Mental Health (CAMH)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CAMH researcher Reza Zomorrodi served as lead investigator on the 2019 Nature Scientific Reports EEG neuromodulation study showing Vielight Neuro Gamma modulates brain oscillations within 20 minutes. First demonstration that home-use PBM device produces significant neuromodulation.

vielight.com
9University of Calgary
Strategic tierMinorTypeStrategic or Co-development Partner
Description

University of Calgary's biophysics lab conducted a cellular study testing Vielight Neuro Pro 2's NIR light on cancer cells, finding differential effects on normal vs. cancer cell metabolism — PBM enhanced viability in normal cells while potentially reducing cancer cell viability under defined conditions. Co-authors include Jack Tuszynsky's team at University of Alberta.

vielight.com
10UCSF
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UCSF fMRI study reveals Vielight Neuro Gamma's 40Hz itPBM improves ADAS-cog scores by 4.8 points, increasing cerebral perfusion and DMN connectivity in Alzheimer's patients. UCSF research validates Vielight's technology for cognitive decline intervention.

vielight.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
1Cognito Therapeutics
TypeDirect peer
Description

Cognito Therapeutics develops light- and sound-based gamma-frequency stimulation devices (Spectris) for Alzheimer's and other neurodegenerative diseases. It is the closest direct competitor to Vielight's Neuro Gamma 40Hz itPBM platform in mechanism and target indication.

2Neuronetics
TypeDirect peer
Description

Neuronetics manufactures transcranial magnetic stimulation (TMS) systems (NeuroStar) for major depressive disorder, an FDA-cleared non-invasive brain stimulation therapy. It is directly comparable to Vielight as a non-invasive neurostimulation device company targeting CNS indications.

3Brainsway
TypeDirect peer
Description

Brainsway markets deep TMS systems (Deep TMS) with FDA-cleared indications in depression, OCD, and smoking cessation. It competes with Vielight in the non-invasive brain stimulation device category targeting psychiatric and neurological disorders.

4electroCore
TypeDirect peer
Description

electroCore makes gammaCore, a non-invasive vagus nerve stimulation (nVNS) device FDA-cleared for migraine, cluster headache, and stroke rehabilitation. It directly overlaps with Vielight's Vagus product line and broader non-invasive neuromodulation positioning.

5Muse (Interaxon)
TypeDirect peer
Description

Muse sells consumer EEG-mediated neurofeedback headbands marketed for sleep, focus, and meditation. It targets the same at-home brain wellness consumer as Vielight Neuro and is integrated with the Vielight-AI EEG analysis platform.

6Emotiv
TypeDirect peer
Description

Emotiv produces consumer and research-grade EEG headsets (EPOC, Insight) used for brain-computer interface, research, and wellness applications. Like Muse, Emotiv is both a Vielight-AI integration partner and a competitor in the consumer neurotech/wellness category.

7MindMaze
TypeEmerging player
Description

MindMaze builds digital neurotherapeutic platforms (MindPod, MindMotion) for stroke rehabilitation and cognitive recovery. It overlaps with Vielight's clinical TBI/stroke-rehabilitation positioning through a software-led, rather than light-based, modality.

8Posit Science (BrainHQ)
TypeBroad incumbent
Description

Posit Science commercializes BrainHQ, a computerized cognitive training platform with clinical evidence in cognitive aging and dementia risk reduction. It is a broad-incumbent peer competing for the same MCI / cognitive-decline customer as Vielight.

9Kernel
TypeEmerging player
Description

Kernel develops non-invasive brain sensing wearables (Flow, Flux) measuring brain activity for cognitive performance and clinical research. It overlaps with Vielight in the premium consumer neurotech category and shares the broader aim of bringing brain metrics out of the clinic.

10Hapbee Technologies
TypeEmerging player
Description

Hapbee sells a wearable that delivers low-power electromagnetic signals for mood, sleep, and wellness effects without drugs. It is a directly adjacent consumer wearable targeting the same wellness/performance buyer as Vielight, though via a different physical modality.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vielight

Consumer Neurotechnologyvielight.com

Vielight, based in Toronto, Canada is increasingly recognized to be the company that offers some of the most user-friendly

What Vielight does

Vielight Inc. is a Toronto-based neurotechnology company founded in 2012 by Dr. Lew Lim that develops and sells at-home photobiomodulation (PBM) devices targeting brain and systemic health. Its core technology is a patented intranasal-transcranial PBM (itPBM) architecture using 810nm near-infrared Vie-LED modules that combine transcranial delivery (via concave-lens modules that bypass hair and scalp) with intranasal delivery through the cribriform plate to reach deep brain structures including the hippocampus, hypothalamus, and brainstem. The product portfolio spans the Neuro 4 series (Gamma 4 at $1,799, Alpha 4, Duo 4 at $2,399, and Pro 2 at $5,000 with 400 mW/cm² irradiance), the MIP multi-wavelength systemic device ($499), the X-Plus 4 for thymus stimulation ($449), and the Vagus NIR vagus nerve stimulator ($699), with devices certified to ISO 13485, MDSAP, and TÜV Rheinland standards.

Vielight sells primarily direct-to-consumer through its e-commerce platform (vielight.com) with global shipping, augmented by a 500+ practitioner channel, elite sports partnerships (BYU football, Haas Factory Team/NASCAR, UFC champion Ilia Topuria), and a government channel via the VA and Lovell Government Services for US veterans. The company also operates VIECLINIC, a Toronto psychiatric and neurological clinic combining EEG, rTMS, tDCS, and tPBM, and is preparing the soft launch of the Vielight-AI platform for EEG analysis in early 2026. Revenue is generated through one-time hardware sales with optional AI platform access bundled in (6-12 months depending on device tier), HSA/FSA eligibility, and reseller/affiliate commissions.

The company has positioned itself as the evidence leader in home-use brain PBM, claiming 30+ peer-reviewed studies with independent top-tier institutions including UCSF, Harvard Medical School, University of Toronto, University of Utah, Baycrest, and CAMH, with 100,000+ devices sold worldwide. A 228-participant pivotal Alzheimer's trial is underway with FDA and Health Canada protocol review, and a $4.6 million US Department of War grant is funding a 300-participant TBI trial at University of Utah and NYU. The company has raised a $3.5 million seed round from MaRS Discovery District and remains founder-controlled under Dr. Lew Lim.

Vielight firmographics

Firmographics
Name
Vielight
Legal name
Vielight Inc.
Website
https://vielight.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Vielight, based in Toronto, Canada is increasingly recognized to be the company that offers some of the most user-friendly
Ownership category
akta.pro rank

Vielight industry classification

Industry
Product category
Consumer Neurotechnology
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHDAHALAL
Optoelectronic Emitters (LED/Laser/VCSEL)

Keywords

  • Brain photobiomodulation devices
  • Near-infrared neurotechnology
  • Intranasal light therapy
  • Transcranial PBM systems
  • Cognitive wellness hardware

Where Vielight is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Vielight business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Hardware device sales: Vielight generates revenue primarily through direct sales of neurotechnology devices (brain PBM headsets and intranasal modules) priced from $449 to $5,000. Devices include Neuro Gamma 4 ($1,799), Neuro Duo 4 ($2,399), Neuro Pro 2 ($5,000), Neuro Alpha 4, MIP, X-Plus, and Vagus. One-time hardware purchase model with optional AI platform access.
  2. VIECLINIC professional services: Vielight operates VIECLINIC, a psychiatric and neurological clinic in Toronto combining EEG, rTMS, tDCS, and tPBM technologies, generating professional services revenue.
  3. Practitioner/reseller programs: Practitioners program enables clinicians to incorporate Vielight brain PBM technology into their practice with dedicated client support channels. Reseller and affiliate programs offer commissions and reseller discounts, creating channel-based revenue.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goVielight Neuro Gamma 4 — Gamma 40Hz brain PBM device
One time/ perpetual licensePay-as-you-goVielight Neuro Duo 4 — Dual Alpha + Gamma device
One time/ perpetual licensePay-as-you-goVielight Neuro Pro 2 — Most powerful customizable brain PBM device
One time/ perpetual licensePay-as-you-goVielight Neuro Alpha 4 — Alpha 10Hz relaxation device
One time/ perpetual licensePay-as-you-goVielight MIP — Multi-wavelength systemic/intranasal device
One time/ perpetual licensePay-as-you-goVielight X-Plus 4 — Thymus and nasal vasculature stimulation
One time/ perpetual licensePay-as-you-goVielight Vagus — Non-invasive vagus nerve stimulation via PBM

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Vielight product offering

Product offering

Core offering

Vielight designs, manufactures, and sells at-home brain photobiomodulation (PBM) devices that deliver 810nm near-infrared light through a patented intranasal-transcranial (itPBM) architecture to reach deep brain structures. Its Neuro product line (Gamma, Alpha, Duo, Pro 2) targets cognition, memory, focus, and recovery, complemented by systemic devices (MIP, X-Plus, Vagus) and an EEG-analysis AI platform. The company also operates VIECLINIC, a Toronto psychiatric and neurological clinic.

Product overview

Vielight is a neurotechnology company offering a portfolio of at-home brain and systemic photobiomodulation (PBM) devices. The core product line includes the Neuro series (Neuro Gamma 4, Neuro Alpha 4, Neuro Duo 4, and Neuro Pro 2) which deliver 810nm near-infrared light via transcranial and intranasal (itPBM) routes to target brain networks. Supporting devices include the MIP for systemic immunity, X-Plus for thymus/nasal stimulation, and Vagus for vagus nerve stimulation. The ecosystem is complemented by the Vielight-AI platform (AI/ML-powered EEG analysis) and VIECLINIC (clinical services). All brain devices use proprietary Vie-LED technology with industry-leading irradiance and are backed by 30+ published peer-reviewed studies.

Differentiator

Problem solved

Functional benefit

Brands

  • Vieclinic: Psychiatric and neurological clinic combining EEG, rTMS, tDCS, and tPBM technologies
  • Vielight Sports
  • Vielight-AI
  • Vie-LED

Products and services

  • Vielight Neuro Gamma 4 Transcranial-intranasal PBM helmet delivering 810nm near-infrared light at 40Hz Gamma frequency via five Vie-LED modules and a patented intranasal applicator, designed to enhance cognition, memory, and brain resilience.
  • Vielight Neuro Alpha 4 Brain PBM device that pulses near-infrared light at 10Hz Alpha frequency through combined transcranial and intranasal delivery to support relaxation, mindfulness, learning, and recovery.
  • Vielight Neuro Duo 4 Dual-frequency brain PBM device that combines Alpha (10Hz) and Gamma (40Hz) pulsed modes, allowing users to switch between relaxed and focused mental states.
  • Vielight Neuro Pro 2 Most powerful and customizable Vielight brain PBM device featuring 9 preset protocols via the Neuro Pro App, 400 mW/cm² irradiance, and a pre-synced smartphone for guided brain photobiomodulation sessions.
  • Vielight MIP 470-633-655-810 Multi-wavelength systemic/intranasal PBM device combining 470, 633, 655, and 810nm light to support immunity, oxygenation, gentle brain stimulation, and intranasal microbial sanitization.
  • Vielight X-Plus 4 Device that stimulates the thymus gland and nasal vasculature with light energy to improve immunity and systemic fitness.
  • Vielight Vagus Non-invasive near-infrared vagus nerve stimulator that uses photobiomodulation to enhance brain-body connectivity, mental clarity, stress reduction, and physical and mental wellbeing.
  • Vielight-AI Platform AI and machine learning platform that analyzes EEG data files to help researchers, clinicians, and home users assess how their brain responds to brain photobiomodulation.
  • VIECLINIC Toronto-based psychiatric and neurological clinic operated by Vielight that combines EEG, rTMS, tDCS, and transcranial PBM technologies for comprehensive neurotechnology-based brain interventions.

Quantifiable outcome

  • Episodic recognition memory improved by large effect size (d=1.09, p=0.02) in MCI patients using Vielight Neuro itPBM for 6 weeks vs. sham
  • +7 more outcomes

Companies that use Vielight

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Vielight technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability4 records

Feature5 records

Vielight partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Haas Factory Team (NASCAR)coreStrategic or Co-development Partner · 18 June 2026Vielight partnered with Haas Factory Team (NASCAR) in June 2026 to bring brain health into the sports conversation. The partnership aims to raise awareness of neurotechnology for athletes, emphasizing brain health considerations from high-speed racing to contact sports. Represents Vielight's expansion into motorsports for visibility and sports performance validation.
  • University of TorontocoreStrategic or Co-development PartnerMultiple research collaborations with University of Toronto including the MCI pilot trial (n=20, published in Journal of Alzheimer's Disease June 2026), ongoing n=60 MCI clinical trial, viral recovery study, and EEG neuromodulation study. Key researchers include Dr. Neda Rashidi-Ranjbar (MD, PhD) and Dr. Corinne Fischer (MD, PhD).
  • St. Michael's Hospital (Toronto)coreStrategic or Co-development PartnerClinical trial site for Vielight's MCI research and pivotal Alzheimer's trial (n=228). St. Michael's Hospital is a major teaching hospital affiliated with the University of Toronto. Dr. Corinne Fischer serves as principal investigator. The hospital's Applied Health Research Centre (AHRC) independently manages the pivotal Alzheimer's trial.
  • University of UtahcoreStrategic or Co-development PartnerMulti-phase TBI research collaboration with University of Utah's Traumatic Brain Injury and Concussion Center. Phase 1 (n=49) and Phase 2 (n=44) published studies showing cognitive and motor improvements. Currently leading the landmark $4.6M DoD-funded 300-participant clinical trial. Key researchers: Dr. Elisabeth Wilde and Dr. Carrie Esopenko. Published in Journal of Neurotrauma (2026).
  • Baycrest HospitalcoreStrategic or Co-development PartnerPublished study (n=45) investigating Vielight's itPBM technology's effect on the brain's glymphatic system (waste clearance network). Key finding: intranasal channel is 20x more efficient than transcranial-only at improving brain fluid dynamics. Study highlights the efficiency advantage of Vielight's dual-pathway approach.
  • Brigham Young University (BYU)coreStrategic or Co-development PartnerBYU football team adopted Vielight Neuro Duo as standard equipment for the 2024 season (11-2 record, No. 13 AP ranking). Tom Holmoe, 3x Super Bowl Champion and BYU Associate Athletic Director, cited compelling photobiomodulation research from University of Utah. Performance research team led by Dr. Coleby Cloawson. Two NFL teams reportedly evaluating the technology.
  • Lovell Government Service / VAcoreChannel Partner/ Reseller/ DistributorPartnership to serve US veterans and service members with Vielight neurotechnology through the VA (Veterans Affairs) system. Provides access to Vielight devices for veterans, particularly those with mTBI and cognitive concerns.
  • Centre for Addiction and Mental Health (CAMH)coreStrategic or Co-development PartnerCAMH researcher Reza Zomorrodi served as lead investigator on the 2019 Nature Scientific Reports EEG neuromodulation study showing Vielight Neuro Gamma modulates brain oscillations within 20 minutes. First demonstration that home-use PBM device produces significant neuromodulation.
  • University of CalgaryminorStrategic or Co-development PartnerUniversity of Calgary's biophysics lab conducted a cellular study testing Vielight Neuro Pro 2's NIR light on cancer cells, finding differential effects on normal vs. cancer cell metabolism — PBM enhanced viability in normal cells while potentially reducing cancer cell viability under defined conditions. Co-authors include Jack Tuszynsky's team at University of Alberta.
  • UCSFcoreStrategic or Co-development PartnerUCSF fMRI study reveals Vielight Neuro Gamma's 40Hz itPBM improves ADAS-cog scores by 4.8 points, increasing cerebral perfusion and DMN connectivity in Alzheimer's patients. UCSF research validates Vielight's technology for cognitive decline intervention.

Scale indicators10 records

Recent moves7 records

Expansion highlights8 records

Vielight competitors and assessment

Company assessment

Direct peers

  • Cognito Therapeutics: Cognito Therapeutics develops light- and sound-based gamma-frequency stimulation devices (Spectris) for Alzheimer's and other neurodegenerative diseases. It is the closest direct competitor to Vielight's Neuro Gamma 40Hz itPBM platform in mechanism and target indication.
  • Neuronetics: Neuronetics manufactures transcranial magnetic stimulation (TMS) systems (NeuroStar) for major depressive disorder, an FDA-cleared non-invasive brain stimulation therapy. It is directly comparable to Vielight as a non-invasive neurostimulation device company targeting CNS indications.
  • Brainsway: Brainsway markets deep TMS systems (Deep TMS) with FDA-cleared indications in depression, OCD, and smoking cessation. It competes with Vielight in the non-invasive brain stimulation device category targeting psychiatric and neurological disorders.
  • electroCore: electroCore makes gammaCore, a non-invasive vagus nerve stimulation (nVNS) device FDA-cleared for migraine, cluster headache, and stroke rehabilitation. It directly overlaps with Vielight's Vagus product line and broader non-invasive neuromodulation positioning.
  • Muse (Interaxon): Muse sells consumer EEG-mediated neurofeedback headbands marketed for sleep, focus, and meditation. It targets the same at-home brain wellness consumer as Vielight Neuro and is integrated with the Vielight-AI EEG analysis platform.
  • Emotiv: Emotiv produces consumer and research-grade EEG headsets (EPOC, Insight) used for brain-computer interface, research, and wellness applications. Like Muse, Emotiv is both a Vielight-AI integration partner and a competitor in the consumer neurotech/wellness category.

Emerging players

  • MindMaze: MindMaze builds digital neurotherapeutic platforms (MindPod, MindMotion) for stroke rehabilitation and cognitive recovery. It overlaps with Vielight's clinical TBI/stroke-rehabilitation positioning through a software-led, rather than light-based, modality.
  • Kernel: Kernel develops non-invasive brain sensing wearables (Flow, Flux) measuring brain activity for cognitive performance and clinical research. It overlaps with Vielight in the premium consumer neurotech category and shares the broader aim of bringing brain metrics out of the clinic.
  • Hapbee Technologies: Hapbee sells a wearable that delivers low-power electromagnetic signals for mood, sleep, and wellness effects without drugs. It is a directly adjacent consumer wearable targeting the same wellness/performance buyer as Vielight, though via a different physical modality.

Broad incumbents

  • Posit Science (BrainHQ): Posit Science commercializes BrainHQ, a computerized cognitive training platform with clinical evidence in cognitive aging and dementia risk reduction. It is a broad-incumbent peer competing for the same MCI / cognitive-decline customer as Vielight.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Vielight social profiles

Digital presence

Vielight compliance and trust

Trust signal

Compliance4 records

Vielight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vielight leadership team

Management profile

Number of profiles

Profiles4 records

Vielight subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Vielight funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vielight M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vielight

What does Vielight do?

Vielight designs, manufactures, and sells at-home brain photobiomodulation (PBM) devices that deliver 810nm near-infrared light through a patented intranasal-transcranial (itPBM) architecture to reach deep brain structures. Its Neuro product line (Gamma, Alpha, Duo, Pro 2) targets cognition, memory, focus, and recovery, complemented by systemic devices (MIP, X-Plus, Vagus) and an EEG-analysis AI platform. The company also operates VIECLINIC, a Toronto psychiatric and neurological clinic.

Is Vielight a public or private company?

Vielight is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Vielight founded?

Vielight was founded in 2011. It employs 11 to 50 people.

Where is Vielight based?

Vielight is headquartered in Toronto, Canada, in the North America region.

How does Vielight make money?

Three revenue lines are on record. Hardware device sales are the primary driver. The others are VIECLINIC professional services and practitioner/reseller programs.

Who are Vielight's main competitors?

Direct peers on record are Cognito Therapeutics, Neuronetics, Brainsway, electroCore, Muse (Interaxon) and Emotiv. Emerging players are MindMaze, Kernel and Hapbee Technologies. Posit Science (BrainHQ) is listed as a broad incumbent.

Does Vielight have an API?

No public API is recorded for Vielight.

What industry is Vielight in?

Vielight's product category is Consumer Neurotechnology. Its primary akta.pro industry code is HDAHALAL, Optoelectronic Emitters (LED/Laser/VCSEL). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAlzheimer's Survivor, 82, Takes on a 650-Mile Cross-Country Challenge from Land's End to LondonDr. Judy Benjamin, an 82-year-old diagnosed with Alzheimer's in 2011, is undertaking a 650-mile walk across England from Land's End to London starting August 1st, 2026, aiming to become the first known Alzheimer's survivor to complete this journey while carrying a message of hope for those affected by cognitive decline. The walk will raise awareness for the ReCODE Protocol developed by neurologist Dr. Dale Bredesen and support the Alzheimer's Survivors Foundation, which Benjamin founded to advocate for individuals living with cognitive decline. Benjamin previously completed a 2,790-mile walk across the United States in 2025 and is sponsored by health and wellness companies including Apollo Health, LifeSeasons, Vielight, Genworth, UCAN, and Xero Shoes.BriefglanceNeurotech's New Dawn: Can Light Therapy Halt Cognitive Decline?Toronto-based neurotechnology firm Vielight announced findings from a peer-reviewed pilot trial published in the Journal of Alzheimer's Disease, where 20 participants with Mild Cognitive Impairment showed statistically significant cognitive improvements after using the company's near-infrared light therapy device at home for 20 minutes daily. The study documented measurable changes in brain connectivity and biological markers tied to cellular energy and inflammation, positioning the non-invasive technology as a potential alternative to pharmaceutical interventions for cognitive decline. Vielight has secured a $3.5 million seed round from MaRS Discovery District and investors, and has a 228-participant pivotal trial underway as it pursues the lengthy FDA approval pathway for medical classification.Gadget Review10 Best Red Light Therapy Devices 2026This article from Gadget Review presents a comprehensive ranking and review of the 10 best red light therapy devices for 2026, evaluating products across multiple categories including pain relief, muscle recovery, skin rejuvenation, hair growth, and neuro wellness. The review covers expert testing, specifications, and customer feedback for devices from brands such as SunPowerLED, Recharge Health, Therasage, Chroma, Kineon, NovaaLab, iRestore, and Vielight. Products are scored across criteria including irradiance, wavelength accuracy, safety, clinical efficacy, and build quality, with prices ranging from $420 to over $1,000.GlobeNewswireUniversity of Toronto Researchers Report Real-Time Brain Fluid Modulation Using Vielight PhotobiomodulationA University of Toronto study found that a 4-minute pulsed photobiomodulation session increased cerebrospinal fluid flow in healthy adults. Intranasal PBM achieved the same effect at about 1/20 the irradiance of forehead PBM and was independent of skin pigmentation. The findings support PBM as a potential non-invasive therapy for neurodegenerative diseases.GlobeNewswireVielight Unveils the First Photobiomodulation-Based Vagus Nerve Stimulation Device Following Patent ApprovalVielight Inc. announced a utility patent for its Vielight Vagus device, the first photobiomodulation-based vagus nerve stimulation system for trans-cervical application. The device uses bilateral 100-Hz pulsed near-infrared light for non-invasive cervical vagus nerve stimulation, with preliminary outcomes showing increased vagal tone. Vielight plans future investigations into VNS applications.GlobeNewswireVielight Unveils Neuro Pro 2: The Most Advanced Transcranial Photobiomodulation Device to DateVielight Inc. launched the Neuro Pro 2, its most advanced transcranial photobiomodulation device, featuring 12 LED modules and customizable parameters. The company cleared its waitlist and is now accepting new orders. The device aims to become a reference platform for personalized therapy research.GlobeNewswireVielight Starts Clinical Trial to Study Photobiomodulation Device Treatment for Post-Covid Cognitive ImpairmentVielight Inc. announced a U.S. clinical trial to test its photobiomodulation device for post-COVID cognitive impairment. The randomized double-blind study enrolls 36 participants, with 18 receiving the active device and 18 a sham. Recruitment is open and will close at 36 subjects.GlobeNewswireVielight Founder, Dr. Lew Lim Granted a Patent for Artificial Intelligence (AI) Brain Stimulation & Assigns to Vielight Inc.The USPTO granted a patent to Dr. Lew Lim for an AI-driven photobiomodulation brain stimulation system, which he assigned to Vielight Inc. The technology uses AI to automate personalized brain modulation via transcranial and intranasal light delivery. Vielight expects the advanced AI model to be commercially available within two years.GlobeNewswireVielight pushes photobiomodulation research to a new level.Vielight Inc. announced the Neuro Pro, a fully programmable transcranial photobiomodulation device. It allows users to set pulse frequencies up to 10,000 Hz and develop delivery protocols, expanding beyond the traditional 0, 10, and 40 Hz. The company plans regular updates and an upcoming webinar on early discoveries.GlobeNewswireVielight pushes photobiomodulation research to a new level.Vielight Inc. announced the Neuro Pro, a fully programmable transcranial photobiomodulation device. It allows users to set pulse frequencies up to 10,000 Hz and develop delivery protocols, expanding beyond the traditional 0, 10, and 40 Hz range. The company plans regular updates and an upcoming webinar on early discoveries.